Responses
Immune cell therapies and immune cell engineering
Original research
Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors
Compose a Response to This Article
Other responses
No responses have been published for this article.